ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
5.87
-0.07 (-1.18%)
At close: Mar 6, 2026
STO:EXPRS2 Market Cap
STO:EXPRS2 has a market cap or net worth of 20.72 million as of March 6, 2026. Its market cap has decreased by -72.93% in one year.
Market Cap
20.72M
Enterprise Value
-25.48M
Revenue
10.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.87
Market Cap Chart
Since July 29, 2016, STO:EXPRS2's market cap has decreased from 117.71M to 20.72M, a decrease of -82.40%. That is a compound annual growth rate of -16.54%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptahem AB | 18.41M |
| Novakand Pharma AB | 15.08M |
| Fluicell AB | 14.84M |
| Guard Therapeutics International AB | 32.27M |
| NanoEcho AB | 12.98M |
| Modus Therapeutics Holding AB | 35.15M |
| Nanologica AB | 35.35M |
| 2cureX AB | 35.65M |